1. Will other drugmakers end up with deals like Endo’s $10M opioid settlement? — AstraZeneca Imfinzi combo fails advanced lung cancer study — FDA says they were “lucky” with Novartis data manipulation controversy — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. What happened a year ago this week in biopharma? Regeneron’s Eylea approval, Novartis’ new ethics czar, Vertex’s Kalydeco, and Opidvo’s SCLC approval click to review and read a current update of the big stories from one year ago
    Dismiss Notice

Muro

Anonymous board for Muro

Sort By:
Title
Replies ↓ Views
Last Message
  1. Anonymous
    Replies:
    30
    Views:
    9,447
  2. Anonymous
    Replies:
    2
    Views:
    4,977

Thread Display Options

Loading...